Goodwin
Felipe M. Heiderich
- Deals
- 3
- Latest
- May 2026
- Most deals in
- Biotech
Firm
- Goodwin Law firm · 2026 · 3 deals
Often works with
- Daniel Karelitz 3 deals together
- Arman Oruc 3 deals together
- Wei Xu 2 deals together
- Andrea Akinbola 2 deals together
- Sam Beavers 2 deals together
- Malhar Naik 2 deals together
- Kevin Walsh 2 deals together
- Stuart Cable 1 deal together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| May 2026 | LimmaTech Biologics AG | – | Eli Lilly and Company | Acquisition | Legal adviser to LimmaTech Biologics AG (target) | Pending | 780.0 | Biotech | Eli Lilly and Company acquisition of LimmaTech Biologics AG |
| Mar 2026 | Ouro Medicines | – | Gilead | Acquisition | Legal adviser to Ouro Medicines (target) | Announced | 1,675.0 | Biotech+1 | Gilead acquisition of Ouro Medicines |
| Feb 2026 | Orna Therapeutics | – | Eli Lilly and Company | Acquisition | Legal adviser to Orna Therapeutics (target) | Announced | 2,400.0 | Biotech+1 | Eli Lilly and Company acquisition of Orna Therapeutics |
Deals where Felipe M. Heiderich is named on the firm's deal team, by the firm or the press.